Human regulatory T cells: role in autoimmune disease and therapeutic opportunities
暂无分享,去创建一个
[1] J. Bluestone,et al. Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction. , 2008, Immunity.
[2] Qizhi Tang,et al. The Foxp3+ regulatory T cell: a jack of all trades, master of regulation , 2008, Nature Immunology.
[3] M. Atkinson,et al. Murine Antithymocyte Globulin Therapy Alters Disease Progression in NOD Mice by a Time-Dependent Induction of Immunoregulation , 2008, Diabetes.
[4] L. Wen,et al. Treatment with CD20-specific antibody prevents and reverses autoimmune diabetes in mice. , 2007, The Journal of clinical investigation.
[5] B. Roep,et al. Differential inhibition of autoreactive memory‐ and alloreactive naive T cell responses by soluble cytotoxic T lymphocyte antigen 4 (sCTLA4), CTLA4Ig and LEA29Y , 2007, Clinical and experimental immunology.
[6] K. Herold,et al. Type 1 diabetes as a relapsing–remitting disease? , 2007, Nature Reviews Immunology.
[7] Christophe Benoist,et al. Foxp3 transcription-factor-dependent and -independent regulation of the regulatory T cell transcriptional signature. , 2007, Immunity.
[8] K. Boyd,et al. The inhibitory cytokine IL-35 contributes to regulatory T-cell function , 2007, Nature.
[9] E. Olson,et al. Deacetylase inhibition promotes the generation and function of regulatory T cells , 2007, Nature Medicine.
[10] G. Prud’homme. Pathobiology of transforming growth factor β in cancer, fibrosis and immunologic disease, and therapeutic considerations , 2007, Laboratory Investigation.
[11] W. Zou,et al. Blocking HDACs boosts regulatory T cells , 2007, Nature Medicine.
[12] Y. Ohsugi. Recent advances in immunopathophysiology of interleukin-6: an innovative therapeutic drug, tocilizumab (recombinant humanized anti-human interleukin-6 receptor antibody), unveils the mysterious etiology of immune-mediated inflammatory diseases. , 2007, Biological & pharmaceutical bulletin.
[13] S. Barry,et al. Isolation, propagation and characterization of cord blood derived CD4+ CD25+ regulatory T cells. , 2007, Journal of immunological methods.
[14] Marian Rewers,et al. The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes , 2007, Proceedings of the National Academy of Sciences.
[15] H. Heslop,et al. Co-expression of cytokine and suicide genes to enhance the activity and safety of tumor-specific cytotoxic T lymphocytes. , 2007, Blood.
[16] Mark Atkinson,et al. Large-scale genetic fine mapping and genotype-phenotype associations implicate polymorphism in the IL2RA region in type 1 diabetes , 2007, Nature Genetics.
[17] P. Teeling,et al. Low Numbers of FOXP3 Positive Regulatory T Cells Are Present in all Developmental Stages of Human Atherosclerotic Lesions , 2007, PloS one.
[18] J. Flier,et al. Modification of adverse inflammation is required to cure new-onset type 1 diabetic hosts , 2007, Proceedings of the National Academy of Sciences.
[19] Y. Belkaid,et al. A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-β– and retinoic acid–dependent mechanism , 2007, The Journal of experimental medicine.
[20] J. Bluestone,et al. CD3-specific antibodies: a portal to the treatment of autoimmunity , 2007, Nature Reviews Immunology.
[21] T. Korn,et al. Anti-thymocyte globulin (ATG) prevents autoimmune encephalomyelitis by expanding myelin antigen-specific Foxp3+ regulatory T cells. , 2007, International immunology.
[22] Terry B. Strom,et al. IL-21 initiates an alternative pathway to induce proinflammatory TH17 cells , 2007, Nature.
[23] E. Shevach,et al. Induction of FOXP3 expression in naive human CD4+FOXP3 T cells by T-cell receptor stimulation is transforming growth factor-beta dependent but does not confer a regulatory phenotype. , 2007, Blood.
[24] R. Steinman,et al. A subset of dendritic cells induces CD4+ T cells to produce IFN-γ by an IL-12–independent but CD70-dependent mechanism in vivo , 2007, The Journal of experimental medicine.
[25] K. Venken,et al. A CFSE based assay for measuring CD4+CD25+ regulatory T cell mediated suppression of auto-antigen specific and polyclonal T cell responses. , 2007, Journal of immunological methods.
[26] M. Atkinson,et al. Treg in type 1 diabetes , 2007, Cell Biochemistry and Biophysics.
[27] S. Rosenberg,et al. Enhanced antitumor activity of T cells engineered to express T-cell receptors with a second disulfide bond. , 2007, Cancer research.
[28] M. Peakman,et al. Translational Mini‐Review Series on Type 1 Diabetes: Systematic analysis of T cell epitopes in autoimmune diabetes , 2007, Clinical and experimental immunology.
[29] Yuan Shen,et al. FOXP3 interactions with histone acetyltransferase and class II histone deacetylases are required for repression , 2007, Proceedings of the National Academy of Sciences.
[30] M. Atkinson,et al. No Alterations in the Frequency of FOXP3+ Regulatory T-Cells in Type 1 Diabetes , 2007, Diabetes.
[31] G. Luo,et al. [Alterations of CD4+ CD25+ regulatory T cells in patients with idiopathic thrombocytopenic purpura]. , 2007, Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi.
[32] N. Perico,et al. Regulatory T cells and T cell depletion: role of immunosuppressive drugs. , 2007, Journal of the American Society of Nephrology : JASN.
[33] K. Papadakis,et al. Expression and functional characterization of FOXP3+CD4+ regulatory T cells in ulcerative colitis , 2007, Inflammatory bowel diseases.
[34] Dale L. Greiner,et al. Humanized mice in translational biomedical research , 2007, Nature Reviews Immunology.
[35] M. Ehrenstein,et al. Anti–TNF-α therapy induces a distinct regulatory T cell population in patients with rheumatoid arthritis via TGF-β , 2007, The Journal of experimental medicine.
[36] R. Steinman,et al. Dendritic cell–expanded, islet-specific CD4+ CD25+ CD62L+ regulatory T cells restore normoglycemia in diabetic NOD mice , 2007, The Journal of experimental medicine.
[37] T. Macdonald,et al. IL-21 Counteracts the Regulatory T Cell-Mediated Suppression of Human CD4+ T Lymphocytes1 , 2007, The Journal of Immunology.
[38] J. Bluestone,et al. New reagents on the horizon for immune tolerance. , 2007, Annual review of medicine.
[39] R. Steinman,et al. Differential Antigen Processing by Dendritic Cell Subsets in Vivo , 2007, Science.
[40] R. Andreesen,et al. Only the CD45RA+ subpopulation of CD4+CD25high T cells gives rise to homogeneous regulatory T-cell lines upon in vitro expansion. , 2006, Blood.
[41] M. Battaglia,et al. Rapamycin Promotes Expansion of Functional CD4+CD25+FOXP3+ Regulatory T Cells of Both Healthy Subjects and Type 1 Diabetic Patients1 , 2006, The Journal of Immunology.
[42] M. Calos. The phiC31 integrase system for gene therapy. , 2006, Current gene therapy.
[43] D. Hommes,et al. Prediction of antitumour necrosis factor clinical efficacy by real-time visualisation of apoptosis in patients with Crohn’s disease , 2006, Gut.
[44] S. Rosenberg,et al. Cancer Regression in Patients After Transfer of Genetically Engineered Lymphocytes , 2006, Science.
[45] P. Emery,et al. Early rheumatoid arthritis is associated with a deficit in the CD4+CD25high regulatory T cell population in peripheral blood. , 2006, Rheumatology.
[46] M. Clare-Salzler,et al. Peptide‐Pulsed Immature Dendritic Cells Reduce Response to β Cell Target Antigens and Protect NOD Recipients from Type I Diabetes , 2006, Annals of the New York Academy of Sciences.
[47] M. Sayegh,et al. A novel mechanism of action for anti-thymocyte globulin: induction of CD4+CD25+Foxp3+ regulatory T cells. , 2006, Journal of the American Society of Nephrology : JASN.
[48] R. González-Amaro,et al. Regulatory T cells in patients with systemic lupus erythematosus. , 2006, Journal of autoimmunity.
[49] F. Sánchez‐Madrid,et al. Regulatory T cells in human autoimmune thyroid disease. , 2006, The Journal of clinical endocrinology and metabolism.
[50] T. Torgerson. Regulatory T cells in human autoimmune diseases , 2006, Springer Seminars in Immunopathology.
[51] J. Bluestone,et al. Suppression of Disease in New Zealand Black/New Zealand White Lupus-Prone Mice by Adoptive Transfer of Ex Vivo Expanded Regulatory T Cells1 , 2006, The Journal of Immunology.
[52] Katharina Fleischhauer,et al. Interleukin‐10‐secreting type 1 regulatory T cells in rodents and humans , 2006, Immunological reviews.
[53] R. Steinman,et al. Dendritic cells expand antigen‐specific Foxp3+CD25+CD4+ regulatory T cells including suppressors of alloreactivity , 2006, Immunological reviews.
[54] A. Rudensky,et al. FOXP3 and NFAT: Partners in Tolerance , 2006, Cell.
[55] T. Gingeras,et al. CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells , 2006, The Journal of experimental medicine.
[56] W. Selby,et al. Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells , 2006, The Journal of experimental medicine.
[57] M. Clare-Salzler,et al. Dendritic cell subsets and type I diabetes: focus upon DC-based therapy. , 2006, Autoimmunity reviews.
[58] Ralph Weissleder,et al. Regulatory T cells reversibly suppress cytotoxic T cell function independent of effector differentiation. , 2006, Immunity.
[59] P. Lipsky,et al. TNF downmodulates the function of human CD4+CD25hi T-regulatory cells. , 2006, Blood.
[60] D. Klatzmann,et al. Regulatory T Cells Control Uveoretinitis Induced by Pathogenic Th1 Cells Reacting to a Specific Retinal Neoantigen1 , 2006, The Journal of Immunology.
[61] K. Venken,et al. Secondary progressive in contrast to relapsing‐remitting multiple sclerosis patients show a normal CD4+CD25+ regulatory T‐cell function and FOXP3 expression , 2006, Journal of neuroscience research.
[62] S. Ziegler,et al. Defective regulatory and effector T cell functions in patients with FOXP3 mutations. , 2006, The Journal of clinical investigation.
[63] T. Maki,et al. Short administration of polyclonal anti-T cell antibody (ALS) in NOD mice with extensive insulitis prevents subsequent development of autoimmune diabetes. , 2006, Journal of autoimmunity.
[64] S. Ziegler,et al. Insights into transcriptional regulation by FOXP3. , 2006, Frontiers in bioscience : a journal and virtual library.
[65] F. Andris,et al. CD4+CD25+ regulatory T cells control the magnitude ofT‐dependent humoral immune responses to exogenous antigens , 2006, European journal of immunology.
[66] M. Hussain,et al. Functional Study of CD4+CD25+ Regulatory T Cells in Health and Autoimmune Hepatitis1 , 2006, The Journal of Immunology.
[67] H. Nawata,et al. An Inverse Correlation of Human Peripheral Blood Regulatory T Cell Frequency with the Disease Activity of Ulcerative Colitis , 2006, Digestive Diseases and Sciences.
[68] C. June,et al. Clinical application of expanded CD4+25+ cells. , 2006, Seminars in immunology.
[69] K. Lynch,et al. Reduction of tissue transglutaminase autoantibody levels by gluten-free diet is associated with changes in subsets of peripheral blood lymphocytes in children with newly diagnosed celiac disease Running title: Tissue transglutaminase autoantibodies and peripheral blood lymphocytes , 2005 .
[70] R. Steinman,et al. The interactions of dendritic cells with antigen-specific, regulatory T cells that suppress autoimmunity. , 2006, Seminars in immunology.
[71] Wenda Gao,et al. CD4+ Regulatory T Cells Are Spared from Deletion by Antilymphocyte Serum, a Polyclonal Anti-T Cell Antibody1 , 2006, The Journal of Immunology.
[72] K. Tsuneyama,et al. Liver‐targeted and peripheral blood alterations of regulatory T cells in primary biliary cirrhosis , 2006, Hepatology.
[73] M. Battaglia,et al. Tr1 cells: from discovery to their clinical application. , 2006, Seminars in immunology.
[74] J. Antel,et al. A new clinically relevant approach to expand myelin specific T cells. , 2006, Journal of immunological methods.
[75] T. Okada,et al. Total Colectomy Improves Altered Distribution of Regulatory T Cells in Patients with Ulcerative Colitis , 2006, World Journal of Surgery.
[76] E. Holler,et al. Isolation of CD4+CD25+ regulatory T cells for clinical trials. , 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[77] H. Drexhage,et al. Aberrant composition of the dendritic cell population in hepatic lymph nodes of patients with hepatocellular carcinoma. , 2006, Human pathology.
[78] P. Debré,et al. The immune paradox of sarcoidosis and regulatory T cells , 2006, The Journal of experimental medicine.
[79] J. She,et al. Physiologic self antigens rapidly capacitate autoimmune disease-specific polyclonal CD4+ CD25+ regulatory T cells. , 2006, Blood.
[80] Yao-Hsu Yang,et al. Inverse correlation between CD4+ regulatory T‐cell population and autoantibody levels in paediatric patients with systemic lupus erythematosus , 2006, Immunology.
[81] A. Bacigalupo. Antithymocyte globulin for prevention of graft-versus-host disease , 2005, Current opinion in hematology.
[82] J. Isaacs,et al. CD4+CD25+ T-regulatory cells are decreased in patients with autoimmune polyendocrinopathy candidiasis ectodermal dystrophy. , 2005, The Journal of allergy and clinical immunology.
[83] A. Akbar,et al. Relative impact of CD4+CD25+ regulatory T cells and tacrolimus on inhibition of T‐cell proliferation in patients with atopic dermatitis , 2005, The British journal of dermatology.
[84] Steven J. Schrodi,et al. PTPN22 genetic variation: evidence for multiple variants associated with rheumatoid arthritis. , 2005, American journal of human genetics.
[85] H. Mcdevitt,et al. Expansion of Functional Endogenous Antigen-Specific CD4+CD25+ Regulatory T Cells from Nonobese Diabetic Mice1 , 2005, The Journal of Immunology.
[86] J. Dahlerup,et al. FoxP3+CD4+CD25+ T cells with regulatory properties can be cultured from colonic mucosa of patients with Crohn's disease , 2005, Clinical and Experimental Immunology.
[87] A. Fattorossi,et al. Circulating and thymic CD4+ CD25+ T regulatory cells in myasthenia gravis: effect of immunosuppressive treatment , 2005, Immunology.
[88] S. Ziegler,et al. Decreased FOXP3 levels in multiple sclerosis patients , 2005, Journal of neuroscience research.
[89] M. Battaglia,et al. Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells. , 2005, Blood.
[90] F. Sallusto,et al. Coexpression of CD25 and CD27 identifies FoxP3+ regulatory T cells in inflamed synovia , 2005, The Journal of experimental medicine.
[91] D. Harlan,et al. A Single Course of Anti-CD3 Monoclonal Antibody hOKT3γ1(Ala-Ala) Results in Improvement in C-Peptide Responses and Clinical Parameters for at Least 2 Years after Onset of Type 1 Diabetes , 2005, Diabetes.
[92] Yu Shyr,et al. Shared gene expression profiles in individuals with autoimmune disease and unaffected first-degree relatives of individuals with autoimmune disease. , 2005, Human molecular genetics.
[93] M. Atkinson,et al. Functional defects and the influence of age on the frequency of CD4+ CD25+ T-cells in type 1 diabetes. , 2005, Diabetes.
[94] P. Isomäki,et al. CD4+ CD25+ T cells with the phenotypic and functional characteristics of regulatory T cells are enriched in the synovial fluid of patients with rheumatoid arthritis , 2005, Clinical and experimental immunology.
[95] D. Porter,et al. T-cell reconstitution and expansion after hematopoietic stem cell transplantation: ‘T’ it up! , 2005, Bone Marrow Transplantation.
[96] F. Kolbinger,et al. An anti-CD45RO/RB monoclonal antibody modulates T cell responses via induction of apoptosis and generation of regulatory T cells , 2005, The Journal of experimental medicine.
[97] B. Yard,et al. Abnormalities of CD4+ T cell subpopulations in ANCA‐associated vasculitis , 2005, Clinical and experimental immunology.
[98] R N Maini,et al. Evidence of radiographic benefit of treatment with infliximab plus methotrexate in rheumatoid arthritis patients who had no clinical improvement: a detailed subanalysis of data from the anti-tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study. , 2005, Arthritis and rheumatism.
[99] Young-Myeong Kim,et al. Critical role of heme oxygenase-1 in Foxp3-mediated immune suppression. , 2005, Biochemical and biophysical research communications.
[100] P. Gottlieb,et al. CD4+CD25high regulatory T cells in human autoimmune diabetes. , 2005, Journal of autoimmunity.
[101] A. Saoudi,et al. Functional defect of regulatory CD4(+)CD25+ T cells in the thymus of patients with autoimmune myasthenia gravis. , 2005, Blood.
[102] D. Bresson,et al. Antigen-Specific Induction of Regulatory T Cells for Type 1 Diabetes Therapy , 2005, International reviews of immunology.
[103] B. Levine,et al. Cord blood CD4(+)CD25(+)-derived T regulatory cell lines express FoxP3 protein and manifest potent suppressor function. , 2004, Blood.
[104] Adrian Vella,et al. Replication of an association between the lymphoid tyrosine phosphatase locus (LYP/PTPN22) with type 1 diabetes, and evidence for its role as a general autoimmunity locus. , 2004, Diabetes.
[105] J. Bluestone,et al. Therapeutic vaccination using CD4+CD25+ antigen-specific regulatory T cells , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[106] R. Bottino,et al. Prolongation of islet allograft survival following ex vivo transduction with adenovirus encoding a soluble type 1 TNF receptor–Ig fusion decoy , 2004, Gene Therapy.
[107] Tetsuya Nakamura,et al. CD4+CD25bright T Cells in Human Intestinal Lamina Propria as Regulatory Cells1 , 2004, The Journal of Immunology.
[108] Toshiro Hara,et al. CD25+CD4+ regulatory T cells in patients with Kawasaki disease. , 2004, The Journal of pediatrics.
[109] M. Bevans,et al. Management of patients receiving antithymocyte globulin for aplastic anemia and myelodysplastic syndrome. , 2004, Clinical journal of oncology nursing.
[110] Steven J. Schrodi,et al. A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. , 2004, American journal of human genetics.
[111] B. Levine,et al. In vitro-expanded human CD4(+)CD25(+) T-regulatory cells can markedly inhibit allogeneic dendritic cell-stimulated MLR cultures. , 2004, Blood.
[112] Ehrenstein,et al. Compromised function of regulatory T cells in rheumatoid arthritis: Reversal by anti-TNF alpha therapy , 2004 .
[113] Jeffrey A. Bluestone,et al. In Vitro–expanded Antigen-specific Regulatory T Cells Suppress Autoimmune Diabetes , 2004, The Journal of experimental medicine.
[114] L. Klareskog,et al. CD25brightCD4+ regulatory T cells are enriched in inflamed joints of patients with chronic rheumatic disease , 2004, Arthritis research & therapy.
[115] R. Steinman,et al. CD25+ CD4+ T Cells, Expanded with Dendritic Cells Presenting a Single Autoantigenic Peptide, Suppress Autoimmune Diabetes , 2004, The Journal of experimental medicine.
[116] F. Dumont. Technology evaluation: abatacept, Bristol-Myers Squibb. , 2004, Current opinion in molecular therapeutics.
[117] B. Stockinger,et al. IL-10-Secreting Regulatory T Cells Do Not Express Foxp3 but Have Comparable Regulatory Function to Naturally Occurring CD4+CD25+ Regulatory T Cells 1 , 2004, The Journal of Immunology.
[118] W. Kuis,et al. CD4+CD25bright Regulatory T Cells Actively Regulate Inflammation in the Joints of Patients with the Remitting Form of Juvenile Idiopathic Arthritis , 2004, The Journal of Immunology.
[119] H. Lorenz,et al. Defective Suppressor Function of Human CD4+ CD25+ Regulatory T Cells in Autoimmune Polyglandular Syndrome Type II , 2004, The Journal of experimental medicine.
[120] J. Piette,et al. CD4+CD25+ regulatory T-cell deficiency in patients with hepatitis C-mixed cryoglobulinemia vasculitis. , 2004, Blood.
[121] Clare Baecher-Allan,et al. Loss of Functional Suppression by CD4+CD25+ Regulatory T Cells in Patients with Multiple Sclerosis , 2004, The Journal of experimental medicine.
[122] A. Rudensky,et al. Molecular aspects of regulatory T cell development. , 2004, Seminars in immunology.
[123] Nunzio Bottini,et al. A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes , 2004, Nature Genetics.
[124] H. Link,et al. Circulating CD4+CD25+ T Regulatory Cells Are Not Altered in Multiple Sclerosis and Unaffected by Disease-Modulating Drugs , 2004, Journal of Clinical Immunology.
[125] L-L Fung,et al. Decreased CD4+CD25+ T Cells in Peripheral Blood of Patients with Systemic Lupus Erythematosus , 2004, Scandinavian journal of immunology.
[126] E. Shevach,et al. Activation requirements for the induction of CD4+CD25+ T cell suppressor function , 2004, European journal of immunology.
[127] Li Li,et al. Conversion of Peripheral CD4+CD25− Naive T Cells to CD4+CD25+ Regulatory T Cells by TGF-β Induction of Transcription Factor Foxp3 , 2003, The Journal of experimental medicine.
[128] L. Chatenoud,et al. Diversity of regulatory CD4+T cells controlling distinct organ-specific autoimmune diseases , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[129] J. Alcocer-Varela,et al. Quantification of regulatory T cells in patients with systemic lupus erythematosus. , 2003, Journal of autoimmunity.
[130] Christopher Baum,et al. Gene Therapy--New Challenges Ahead , 2003, Science.
[131] T. Strom,et al. Favorably tipping the balance between cytopathic and regulatory T cells to create transplantation tolerance. , 2003, Immunity.
[132] J. Bluestone,et al. Cutting Edge: CD28 Controls Peripheral Homeostasis of CD4+CD25+ Regulatory T Cells 1 , 2003, The Journal of Immunology.
[133] J. Bach. Autoimmune Diseases as the Loss of Active “Self‐Control” , 2003, Annals of the New York Academy of Sciences.
[134] J. Bluestone,et al. TGF-β-dependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes , 2003, Nature Medicine.
[135] T. Kitamura,et al. Reconstitution of CD8+ T Cells by Retroviral Transfer of the TCR αβ-Chain Genes Isolated from a Clonally Expanded P815-Infiltrating Lymphocyte1 , 2003, The Journal of Immunology.
[136] R. Steinman,et al. Direct Expansion of Functional CD25+ CD4+ Regulatory T Cells by Antigen-processing Dendritic Cells , 2003, The Journal of experimental medicine.
[137] H. Spits,et al. Ectopic hTERT expression extends the life span of human CD4+ helper and regulatory T-cell clones and confers resistance to oxidative stress-induced apoptosis. , 2003, Blood.
[138] Luc J. Smink,et al. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease , 2003, Nature.
[139] U. Grohmann,et al. Tolerance, DCs and tryptophan: much ado about IDO. , 2003, Trends in immunology.
[140] F. Powrie,et al. Cutting Edge: Cure of Colitis by CD4+CD25+ Regulatory T Cells1 , 2003, The Journal of Immunology.
[141] T. Hünig,et al. Efficient expansion of regulatory T cells in vitro and in vivo with a CD28 superagonist , 2003, European journal of immunology.
[142] Ruslan Medzhitov,et al. Toll Pathway-Dependent Blockade of CD4+CD25+ T Cell-Mediated Suppression by Dendritic Cells , 2003, Science.
[143] Marcela V Maus,et al. A cell-based artificial antigen-presenting cell coated with anti-CD3 and CD28 antibodies enables rapid expansion and long-term growth of CD4 T lymphocytes. , 2002, Clinical immunology.
[144] J. Bach. [Current concepts of autoimmunity]. , 2002, Revue neurologique.
[145] C. Janeway,et al. Expression of transgene encoded TGF-beta in islets prevents autoimmune diabetes in NOD mice by a local mechanism. , 2002, Journal of autoimmunity.
[146] A. Enk,et al. Infectious Tolerance , 2002, The Journal of experimental medicine.
[147] B. Blazar,et al. The infusion of ex vivo activated and expanded CD4(+)CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality. , 2002, Blood.
[148] A. Shapiro,et al. Combination therapy with sirolimus and interleukin-2 prevents spontaneous and recurrent autoimmune diabetes in NOD mice. , 2002, Diabetes.
[149] M. Byrne,et al. CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. , 2002, Immunity.
[150] A. Weinberg. OX40: targeted immunotherapy--implications for tempering autoimmunity and enhancing vaccines. , 2002, Trends in immunology.
[151] J. Puck,et al. Immunophenotypic profiles in families with autoimmune lymphoproliferative syndrome. , 2001, Blood.
[152] J. Bluestone,et al. Suppressor T cells – they’re back and critical for regulation of autoimmunity! , 2001, Immunological reviews.
[153] G. Freeman,et al. CD4+CD25high Regulatory Cells in Human Peripheral Blood1 , 2001, The Journal of Immunology.
[154] J. Gutiérrez-Ramos,et al. Importance of ICOS–B7RP-1 costimulation in acute and chronic allograft rejection , 2001, Nature Immunology.
[155] R. de Waal Malefyt,et al. IFN-α and IL-10 Induce the Differentiation of Human Type 1 T Regulatory Cells1 , 2001, The Journal of Immunology.
[156] Christopher B Wilson,et al. Role of CD28/CD80-86 and CD40/CD154 Costimulatory Interactions in Host Defense to Primary Herpes Simplex Virus Infection , 2001, Journal of Virology.
[157] W. van Eden,et al. 'Anergic' T cells modulate the T-cell activating capacity of antigen-presenting cells. , 2000, Journal of autoimmunity.
[158] J. Bluestone,et al. B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. , 2000, Immunity.
[159] R. Fisher,et al. Long-term survival update for high-dose recombinant interleukin-2 in patients with renal cell carcinoma. , 2000, The cancer journal from Scientific American.
[160] S. Ziegler,et al. Cellular and molecular characterization of the scurfy mouse mutant. , 1999, Journal of Immunology.
[161] M. Toda,et al. Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. , 1998, International immunology.
[162] J. Bluestone,et al. Partial TCR signals delivered by FcR-nonbinding anti-CD3 monoclonal antibodies differentially regulate individual Th subsets. , 1998, Journal of immunology.
[163] G. Pawelec,et al. Human T‐cell clones in long‐term culture as a model of immunosenescence , 1997, Immunological reviews.
[164] G. Pawelec,et al. Replicative senescence of T cells: does the Hayflick Limit lead to immune exhaustion? , 1997, Immunology today.
[165] M. Detmar,et al. Animal models of psoriasis , 1997, Nature Medicine.
[166] J. Bluestone,et al. Nonmitogenic Anti-CD3 Monoclonal Antibodies Deliver a Partial T Cell Receptor Signal and Induce Clonal Anergy , 1997, The Journal of experimental medicine.
[167] S. Sakaguchi,et al. Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation , 1996, The Journal of experimental medicine.
[168] Nitin J. Karandikar,et al. CTLA-4: a negative regulator of autoimmune disease , 1996, The Journal of experimental medicine.
[169] M. Toda,et al. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. , 1995, Journal of immunology.
[170] D. Kioussis,et al. "Infectious" transplantation tolerance , 1993, Science.
[171] T. Miyawaki,et al. Immunohistologic localization and immune phenotypes of lymphocytes expressing Tac antigen in human lymphoid tissues. , 1984, Journal of immunology.
[172] D. Guberski,et al. Spontaneous diabetes mellitus: reversal and prevention in the BB/W rat with antiserum to rat lymphocytes. , 1979, Science.
[173] N. Mitchison,et al. STUDIES ON THE IMMUNOLOGICAL RESPONSE TO FOREIGN TUMOR TRANSPLANTS IN THE MOUSE , 1955, The Journal of experimental medicine.
[174] L. Naldini,et al. Generation of potent and stable human CD4+ T regulatory cells by activation-independent expression of FOXP3. , 2008, Molecular therapy : the journal of the American Society of Gene Therapy.
[175] R. Negrin,et al. Differential impact of mammalian target of rapamycin inhibition on CD4+CD25+Foxp3+ regulatory T cells compared with conventional CD4+ T cells. , 2008, Blood.
[176] A. Torgashina,et al. Reduced number and function of CD4+CD25highFoxP3+ regulatory T cells in patients with systemic lupus erythematosus. , 2007, Advances in experimental medicine and biology.
[177] D. Mottet,et al. Histone deacetylases: target enzymes for cancer therapy , 2007, Clinical & Experimental Metastasis.
[178] Pau Serra,et al. Visualizing regulatory T cell control of autoimmune responses in nonobese diabetic mice , 2006, Nature Immunology.
[179] T. Hanke,et al. CD28 superagonists put a break on autoimmunity by preferentially activating CD4+CD25+ regulatory T cells. , 2006, Autoimmunity reviews.
[180] C. Akdis,et al. Absence of T-regulatory cell expression and function in atopic dermatitis skin. , 2006, The Journal of allergy and clinical immunology.
[181] M. Peakman,et al. Defective suppressor function in CD4(+)CD25(+) T-cells from patients with type 1 diabetes. , 2005, Diabetes.
[182] A. Fattorossi,et al. Circulating CD4+CD25+ T regulatory and natural killer T cells in patients with myasthenia gravis: a flow cytometry study. , 2005, Journal of biological regulators and homeostatic agents.
[183] P. Novota,et al. Polyclonal anti-T-cell therapy for type 1 diabetes mellitus of recent onset. , 2004, The review of diabetic studies : RDS.
[184] G. Freeman,et al. CD4+CD25+ regulatory cells from human peripheral blood express very high levels of CD25 ex vivo. , 2003, Novartis Foundation symposium.
[185] David A. Williams,et al. Medicine. Gene therapy--new challenges ahead. , 2003, Science.
[186] Svetlana Ten,et al. Multiple immuno-regulatory defects in type-1 diabetes. , 2002, The Journal of clinical investigation.
[187] D. Birx,et al. Adoptive transfer of costimulated CD4+ T cells induces expansion of peripheral T cells and decreased CCR5 expression in HIV infection , 2002, Nature Medicine.
[188] J. Casanova,et al. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy , 2001, Nature Genetics.
[189] H. Ochs,et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3 , 2001, Nature Genetics.
[190] D. Galas,et al. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse , 2001, Nature Genetics.
[191] R. de Waal Malefyt,et al. IFN-alpha and IL-10 induce the differentiation of human type 1 T regulatory cells. , 2001, Journal of immunology.
[192] M. Fussenegger,et al. Genetic optimization of recombinant glycoprotein production by mammalian cells. , 1999, Trends in biotechnology.
[193] B. Nelson,et al. Biology of the interleukin-2 receptor. , 1998, Advances in immunology.
[194] J. V. van Noort. Antigen-specific therapies in multiple sclerosis. , 1998, Biotherapy.
[195] J. S. Wilkinson. Spontaneous diabetes mellitus. , 1960 .